ANGIOTENSIN II RECEPTOR TYPE 1 (AT1) AUTOANTIBODIES IN PATIENTS WITH PRIMARY ALDOSTERONISM

被引:0
|
作者
Waraich, Ms Jotinder [1 ]
Kline, Gregory A. [2 ]
Choi, May Y. [3 ]
Sigal, Ronald J. [4 ,5 ,6 ]
Caughlin, Cori [7 ]
Przybojewski, Stefan J. [7 ]
Leung, Alexander A. [4 ,6 ]
机构
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Univ Calgary, Dept Med, Div Rheumatol, Calgary, AB, Canada
[4] Univ Calgary, Dept Med, Calgary, AB, Canada
[5] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada
[6] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[7] Univ Calgary, Dept Radiol, Calgary, AB, Canada
关键词
Primary Aldosteronism; Hypertension; Autoantibody; Immunology;
D O I
10.1097/01.hjh.0001063084.70004.b7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
P053
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism
    Meyer, Lucie S.
    Gong, Siyuan
    Reincke, Martin
    Williams, Tracy Ann
    HORMONE AND METABOLIC RESEARCH, 2020, 52 (06) : 379 - 385
  • [2] Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism
    Williams, Tracy Ann
    Jaquin, Diana
    Burrello, Jacopo
    Philippe, Aurelie
    Yang, Yuhong
    Rank, Petra
    Nirschl, Nina
    Sturm, Lisa
    Huebener, Christoph
    Dragun, Duska
    Bidlingmaier, Martin
    Beuschlein, Felix
    Reincke, Martin
    HYPERTENSION, 2019, 74 (04) : 784 - 792
  • [3] ANGIOTENSIN II TYPE 1 RECEPTOR AUTOANTIBODIES: CAUSE OR CONSEQUENCE OF HUMAN PRIMARY ALDOSTERONISM?
    Piazza, M.
    Seccia, T. M.
    Caroccia, B.
    Rossitto, G.
    Rossi, G. P.
    JOURNAL OF HYPERTENSION, 2019, 37 : E283 - E283
  • [4] Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism
    Li, Hongliang
    Yu, Xichun
    Cicala, Maria Verena
    Mantero, Franco
    Benbrook, Alexandria
    Veitla, Vineet
    Cunningham, Madeleine W.
    Kem, David C.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (01) : 15 - 20
  • [5] AT1AA (Angiotensin II Type-1 Receptor Autoantibodies) Cause or Consequence of Human Primary Aldosteronism?
    Piazza, Maria
    Seccia, Teresa Maria
    Caroccia, Brasilina
    Rossitto, Giacomo
    Scarpa, Riccardo
    Persichitti, Perla
    Basso, Daniela
    Rossi, Gian Paolo
    HYPERTENSION, 2019, 74 (04) : 793 - 799
  • [6] Autoimmune Mechanisms Activating the Angiotensin AT1 Receptor in 'Primary' Aldosteronism
    Kem, David C.
    Li, Hongliang
    Velarde-Miranda, Carolina
    Liles, Campbell
    Vanderlinde-Wood, Megan
    Galloway, Allison
    Khan, Muneer
    Zillner, Caitlin
    Benbrook, Alexandria
    Rao, Veitla
    Gomez-Sanchez, Celso E.
    Cunningham, Madeleine W.
    Yu, Xichun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05): : 1790 - 1797
  • [7] Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia
    Wallukat, G
    Neichel, D
    Nissen, E
    Homuth, V
    Luft, F
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 79 - 83
  • [8] Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension
    Fu, MLX
    Herlitz, H
    Schulze, W
    Wallukat, G
    Micke, P
    Eftekhari, P
    Sjögren, KG
    Hjalmarson, Å
    Müller-Esterl, W
    Hoebeke, J
    JOURNAL OF HYPERTENSION, 2000, 18 (07) : 945 - 953
  • [9] Regulation of angiotensin II type 1 (AT1) receptor function
    Thomas, WG
    REGULATORY PEPTIDES, 1999, 79 (01) : 9 - 23
  • [10] Stimulatory autoantibodies against the angiotensin II AT1 receptor in patients with preeclampsia and HELLP syndrom
    Wallukat, G
    Dechend, R
    Hohmuth, V
    Fischer, T
    Neichel, D
    Nissen, E
    Luft, FC
    AUTOANTIGENS AND AUTOANTIBODIES: DIAGNOSTIC TOOLS AND CLUES TO UNDERSTANDING AUTOIMMUNITY, 2000, 1 : 285 - 285